Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 Minority Interest

As of the most recent data (June 2026), BLACR shows a minority interest of $21M. That compares with $55M in the prior-year period — down 62.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLACR's minority interest is now $21M (was $55M) — a 62.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 is outperforming or lagging.

Tracking BLACR's minority interest over time shows whether Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 is scaling, shrinking, or reshaping that part of the business. The current reading is $21M That compares with $55M in the prior-year period — down 62.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $21M) with ownership activity and broader fundamentals.